Genetic Characterization of HIV Before Widespread Testing of HIV Vaccine Candidates at a Clinical Trial Site in Pretoria, South Africa

被引：0

作者：

Musyoki, Andrew ^{[1
]}

Mothapo, Khutso ^{[1
]}

Rakgole, Johnny ^{[1
]}

Lukhwareni, Azwidowi ^{[1
]}

Bessong, Pascal ^{[2
]}

Selabe, Gloria ^{[1
]}

Bredell, Helba ^{[3
]}

Williamson, Carolyn ^{[3
]}

Mphahlele, M. Jeffrey ^{[1
]}

机构：

[1] Univ Limpopo, Natl Hlth Lab Serv, Dept Virol, HIV & Hepatitis Res Unit, Pretoria, South Africa

[2] Univ Venda, Dept Microbiol, AIDS Virus Res Lab, Thohoyandou, South Africa

[3] Univ Cape Town, Natl Hlth Lab Serv, Div Med Virol, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa

来源：

AIDS RESEARCH AND HUMAN RETROVIRUSES | 2012年 / 28卷 / 09期

基金：

英国医学研究理事会; 新加坡国家研究基金会;

关键词：

IMMUNODEFICIENCY-VIRUS TYPE-1; DIVERSITY; VPR; SEQUENCES; GAG; VIF;

D O I：

10.1089/aid.2011.0285

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

We studied 123 samples from adult chronic HIV patients initiating HAART from various centers around a newly established clinical trial site in Pretoria. Each sample was sequenced in at least one structural gene (pol, gag, and env) or functional gene (vif, vpr, and vpu). A subset of 25 samples was subjected to near full-genome analysis. All samples were HIV-1 subtype C. Highly conserved-regions within the gene sequences were observed. Overall, the gag and vif sequences showed closer similarity followed by the env, vpr, pol, and vpu. The env gene was the most difficult to sequence, resulting in only 31 sequences from 40 samples; of these, 25 were predicted to be R5 coreceptor tropic, while 6 were X4 tropic. The study asserted the predominance of HIV-1 subtype C within the catchment population.

引用

页码：931 / 938

页数：8

共 50 条

[31] Willingness to use HIV prevention methods among vaccine efficacy trial participants in Soweto, South Africa: discretion is important
Laher, Fatima
Salami, Taibat
Hornschuh, Stefanie
Makhale, Lerato M.
Khunwane, Mamakiri
Andrasik, Michele P.
Gray, Glenda E.
Van Tieu, Hong
Dietrich, Janan J.
BMC PUBLIC HEALTH, 2020, 20 (01)
[32] Uptake of Genital Mucosal Sampling in HVTN 097, a Phase 1b HIV Vaccine Trial in South Africa
Lazarus, Erica Maxine
Otwombe, Kennedy
Adonis, Tania
Sebastian, Elaine
Gray, Glenda
Grunenberg, Nicole
Roux, Surita
Churchyard, Gavin
Innes, Craig
Laher, Fatima
PLOS ONE, 2014, 9 (11):
[33] Willingness to use HIV prevention methods among vaccine efficacy trial participants in Soweto, South Africa: discretion is important
Fatima Laher
Taibat Salami
Stefanie Hornschuh
Lerato M. Makhale
Mamakiri Khunwane
Michele P. Andrasik
Glenda E. Gray
Hong Van Tieu
Janan J. Dietrich
BMC Public Health, 20
[34] What role do communities play in scientific research? Exploring community perspectives on HIV/AIDS and trial participation at a HIV vaccine research centre in South Africa
Lesch, Anthea
Swartz, Leslie
Roux, Surita
INTERNATIONAL JOURNAL OF PSYCHOLOGY, 2012, 47 : 468 - 468
[35] Non-nucleoside reverse transcriptase inhibitor levels among HIV-exposed uninfected infants at the time of HIV PCR testing - findings from a tertiary healthcare facility in Pretoria, South Africa
Mazanderani, Ahmad Haeri
Murray, Tanya Y.
Sherman, Gayle G.
Snyman, Tracy
George, Jaya
Avenant, Theunis
Goga, Ameena E.
Pepper, Michael S.
du Plessis, Nicolette
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2019, 22 (06)
[36] HIV self-testing among young women in rural South Africa: A randomized controlled trial comparing clinic-based HIV testing to the choice of either clinic testing or HIV self-testing with secondary distribution to peers and partners
Pettifor, Audrey
Lippman, Sheri A.
Kimaru, Linda
Haber, Noah
Mayakayaka, Zola
Selin, Amanda
Twine, Rhian
Gilmore, Hailey
Westreich, Daniel
Mdaka, Brian
Wagner, Ryan
Gomez-Olive, Xavier
Tollman, Stephen
Kahn, Kathleen
ECLINICALMEDICINE, 2020, 21
[37] Identification and Genetic Characterization of Unique HIV-1 A1/C Recombinant Strain in South Africa
Musyoki, Andrew M.
Rakgole, Johnny N.
Selabe, Gloria
Mphahlele, Jeffrey
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2015, 31 (03) : 347 - 352
[38] Universal HIV testing and treatment and HIV stigma reduction: a comparative thematic analysis of qualitative data from the HPTN 071 (PopART) trial in South Africa and Zambia
Viljoen, Lario
Bond, Virginia A.
Reynolds, Lindsey J.
Mubekapi-Musadaidzwa, Constance
Baloyi, Dzunisani
Ndubani, Rhoda
Stangl, Anne
Seeley, Janet
Pliakas, Triantafyllos
Bock, Peter
Fidler, Sarah
Hayes, Richard
Ayles, Helen
Hargreaves, James R.
Hoddinott, Graeme
SOCIOLOGY OF HEALTH & ILLNESS, 2021, 43 (01) : 167 - 185
[39] The association between HIV stigma and HIV incidence in the context of universal testing and treatment: analysis of data from the HPTN 071 (PopART) trial in Zambia and South Africa
Hargreaves, James R.
Pliakas, Triantafyllos
Hoddinott, Graeme
Mainga, Tila
Mubekapi-Musadaidzwa, Constance
Donnell, Deborah
Wilson, Ethan
Piwowar-Manning, Estelle
Agyei, Yaw
Bell-Mandla, Nomtha F.
Dunbar, Rory
Schaap, Ab
Macleod, David
Floyd, Sian
Bock, Peter
Fidler, Sarah
Seeley, Janet
Stangl, Anne
Bond, Virginia
Ayles, Helen
Hayes, Richard J.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2022, 25
[40] Test and Treat TB: a pilot trial of GeneXpert MTB/RIF screening on a mobile HIV testing unit in South Africa
Ingrid V. Bassett
Leah S. Forman
Sabina Govere
Hilary Thulare
Simone C. Frank
Bright Mhlongo
Elena Losina
BMC Infectious Diseases, 19

← 1 2 3 4 5 →